Published in
Massachusetts Medical Society, New England Journal of Medicine, 11(387), p. 978-988, 2022
Links
Tools
Rivaroxaban in Rheumatic Heart Disease–Associated Atrial Fibrillation
Journal article published in 2022 by
Stuart J. Connolly 
,
Ganesan Karthikeyan ,
Mpiko Ntsekhe,
Abraham Haileamlak,
Ahmed El Sayed,
Alaa El Ghamrawy,
Albertino Damasceno,
Alvaro Avezum,
Antonio M. L. Dans,
Bernard Gitura,
Dayi Hu,
Emmanuel R. Kamanzi,
Fathi Maklady,
Golden Fana,
J. Antonio Gonzalez-Hermosillo
and other authors.
,
Ganesan Karthikeyan ,
Mpiko Ntsekhe,
Abraham Haileamlak,
Ahmed El Sayed,
Alaa El Ghamrawy,
Albertino Damasceno,
Alvaro Avezum,
Antonio M. L. Dans,
Bernard Gitura,
Dayi Hu,
Emmanuel R. Kamanzi,
Fathi Maklady,
Golden Fana,
J. Antonio Gonzalez-Hermosillo
and other authors.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
Full text: Unavailable
Data provided by 